Novavax Inc (NVAX) 45.02 usd,+0.18, +0.40%
Novavax today is trading on 45.02usd. Novavax announced that its Company is going to acquire small-cap biotech that is in Czech called Praha for 167 million in cash. The company is going to join Novavax where it will heavily boost its manufacturing capacity for the coronavirus vaccine. Novavax will retain Praha's existing employees to keep the whole operation functioning. Novavax estimates that it will be able to produce more than 1 billion doses of its SARS-CoV-2 vaccine candidate, NVX-CoV2373, in 2021 and this actually boosted the gains for the Company